Select delivery option
You have no items in your shopping cart.
Potent transcriptional activation using CRISPRa with synthetic crRNA
Category: Research Services
CRISPR screening in xenograft models for in vivo drug MOA analysis
Category: In Vivo Models
Comparison of cfDNA Reference Material Prepared using Enzymatic Fragmentation or Sonica...
Category: Reference Standards
High-Throughput Cell Panel and Organoid Screening in 3D
Reference Standards for the validation of myeloid sequencing assays
APOE Epsilon 4 Knock-In Rat Model of Alzheimer’s Disease
ATL313, a Novel Drug Candidate for the Treatment of Multiple Myeloma
OncoSignature HT screening platform for the prediction of anticancer drug sensitivity
Cell based screens for immuno-oncology discovery research
Genetic screening with CRISPR-Cas9: Proof & Principles
Biomarker-based pooled CRISPR-Cas9 screening: Platform development and validation
CRISPR-Cas9: a tool for rapid target discovery and validation
P450 induction in cryopreserved hepatocytes from PXR and CAR nuclear receptor KO rats
Genetic Toolbox for Neuroscience
Dual CRISPRi & CRISPRa screening reveals phenotypic switches in BRAF inhibition
Modelling Neurological Disease: In Vitro Gene Editing and iPSC Differentiation Combine ...
Category: Cell Lines
1-16 of 80
© 2019 Horizon Discovery Group plc, Company Registration Number 08921143